tiprankstipranks
Centessa Pharmaceuticals (CNTA)
NASDAQ:CNTA
US Market
CNTA
Centessa Pharmaceuticals
RESEARCH TOOLSreports

Centessa Pharmaceuticals (CNTA) Income Statement

235 Followers

Centessa Pharmaceuticals Income Statement

Last quarter (Q4 2025), Centessa Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Centessa Pharmaceuticals's net income was $-66.16M. See Centessa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 15.00M$ 0.00$ 6.85M$ 0.00$ 0.00
Gross Profit
$ 15.00M$ 0.00$ 6.85M$ 0.00$ 0.00
Operating Expenses
$ 222.69M$ 201.06M$ 178.14M$ 212.26M$ 374.87M
Depreciation and Amortization
$ 0.00$ 942.00K$ 810.00K$ 131.00K$ 34.00K
EBITDA
$ -207.69M$ -221.88M$ -165.43M$ -209.55M$ -139.30M
Operating Income
$ -207.69M$ -201.06M$ -171.28M$ -212.26M$ -374.87M
Other Income/Expenses
$ 11.98M$ -31.86M$ -4.86M$ -4.69M$ -6.92M
Pretax Income
$ -195.71M$ -232.91M$ -176.14M$ -216.95M$ -381.79M
Net Income
$ -197.53M$ -235.76M$ -151.09M$ -216.21M$ -381.90M
Per Share Metrics
Basic EPS
$ -1.46$ -2.06$ -1.57$ -2.31$ -4.24
Diluted EPS
$ -1.46$ -2.06$ -1.57$ -2.31$ -4.24
Weighted Average Shares Outstanding
 135.72M 114.47M 96.18M 93.40M 89.99M
Weighted Average Shares Outstanding (Diluted)
 135.72M 114.47M 96.18M 93.40M 89.99M
Currency in USD

Centessa Pharmaceuticals Earnings and Revenue History